1. Home
  2. SNSE vs SUGP Comparison

SNSE vs SUGP Comparison

Compare SNSE & SUGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • SUGP
  • Stock Information
  • Founded
  • SNSE 2005
  • SUGP 1998
  • Country
  • SNSE United States
  • SUGP Hong Kong
  • Employees
  • SNSE N/A
  • SUGP N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • SUGP
  • Sector
  • SNSE Health Care
  • SUGP
  • Exchange
  • SNSE Nasdaq
  • SUGP NYSE
  • Market Cap
  • SNSE 9.3M
  • SUGP 9.6M
  • IPO Year
  • SNSE 2021
  • SUGP 2024
  • Fundamental
  • Price
  • SNSE $8.69
  • SUGP $0.50
  • Analyst Decision
  • SNSE Strong Buy
  • SUGP
  • Analyst Count
  • SNSE 3
  • SUGP 0
  • Target Price
  • SNSE $86.67
  • SUGP N/A
  • AVG Volume (30 Days)
  • SNSE 12.2K
  • SUGP 149.1K
  • Earning Date
  • SNSE 08-05-2025
  • SUGP 07-21-2025
  • Dividend Yield
  • SNSE N/A
  • SUGP N/A
  • EPS Growth
  • SNSE N/A
  • SUGP 1.19
  • EPS
  • SNSE N/A
  • SUGP 0.11
  • Revenue
  • SNSE N/A
  • SUGP $23,446,259.00
  • Revenue This Year
  • SNSE N/A
  • SUGP N/A
  • Revenue Next Year
  • SNSE N/A
  • SUGP N/A
  • P/E Ratio
  • SNSE N/A
  • SUGP $4.75
  • Revenue Growth
  • SNSE N/A
  • SUGP 11.29
  • 52 Week Low
  • SNSE $5.00
  • SUGP $0.35
  • 52 Week High
  • SNSE $17.40
  • SUGP $3.25
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 63.87
  • SUGP 34.00
  • Support Level
  • SNSE $5.86
  • SUGP $0.47
  • Resistance Level
  • SNSE $8.74
  • SUGP $0.66
  • Average True Range (ATR)
  • SNSE 0.75
  • SUGP 0.08
  • MACD
  • SNSE 0.25
  • SUGP -0.02
  • Stochastic Oscillator
  • SNSE 88.54
  • SUGP 30.36

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About SUGP SU GROUP HLDGS LTD

SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment. Geographically operates in Hong Kong, and Other foreign countries, with maximum revenue from Kong Kong.

Share on Social Networks: